---
title: "ENSG: Q2 2026 delivered double-digit earnings growth, higher guidance, and robust acquisition activity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293914447.md"
description: "Q2 2026 saw strong revenue and earnings growth, with GAAP EPS up 16.7% and adjusted EPS up 20.8% year-over-year. Occupancy and skilled mix improved, guidance for 2026 was raised, and 20 new operations were acquired, supporting long-term growth.Original document: The Ensign Group, Inc. [ENSG] SEC 8-K Current Report — Jul. 27 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-27T10:10:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293914447.md)
  - [en](https://longbridge.com/en/news/293914447.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293914447.md)
generator: "portal-rs"
---

# ENSG: Q2 2026 delivered double-digit earnings growth, higher guidance, and robust acquisition activity

Q2 2026 saw strong revenue and earnings growth, with GAAP EPS up 16.7% and adjusted EPS up 20.8% year-over-year. Occupancy and skilled mix improved, guidance for 2026 was raised, and 20 new operations were acquired, supporting long-term growth.

Original document: The Ensign Group, Inc. \[ENSG\] SEC 8-K Current Report — Jul. 27 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ENSG.US](https://longbridge.com/en/quote/ENSG.US.md)

## Related News & Research

- [17:43 ETRosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG](https://longbridge.com/en/news/296404558.md)
- [5,846,650 Shares in The Ensign Group, Inc. $ENSG Purchased by BlackRock Inc.](https://longbridge.com/en/news/296694543.md)
- [BEWI: Q2 2026 delivered double-digit sales and EBITDA growth, with strong performance across all segments](https://longbridge.com/en/news/296303987.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**